Bayer Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...

First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival ...

In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 ...

Many patients with ER-positive/HER2-negative advanced breast cancer eventually develop resistance to standard first-line ...

Company continues to progress both REYOBIQ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced results from a study of treatment patterns among patients with tardive dyskinesia (TD) residing in ...

Macau, Macau Business, MAG, MB, MB Featured, MNA, MNA Featured | The first successful tech-to-industry enterprise from the ...

Mr Patrick Ssesazi, the implementation lead of medical drones at IDI, said the drones that were used during the second phase ...